Immunointervention in Man : A Critique of Clinical Trial Methodology (Record no. 1561)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02148nam a2200217 a 4500 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| ISBN | 0192619187 (hardcover) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| ISBN | 9780192619181 (hardcover) |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 615.37 Wallace 13623 1st 1991 Pharmacology |
| 100 1# - MAIN ENTRY--AUTHOR NAME | |
| Personal name | Wallace, Keith H. |
| 245 10 - TITLE STATEMENT | |
| Title | Immunointervention in Man : A Critique of Clinical Trial Methodology |
| 250 ## - EDITION STATEMENT | |
| Edition statement | 1st ed. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Place of publication | New York : |
| Name of publisher | Oxford University Press; |
| Year of publication | 1991. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Number of Pages | 238 p. ; |
| 490 1# - SERIES STATEMENT | |
| Series statement | Oxford medical publications. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc | A clinical trial, involving evaluation of the safety and efficacy of drugs which may ultimately be administered to millions of people, represents one of the most important applications of the scientific method. However, the design of a valid trial is quite subtle, and misleading results can easily be obtained with poor technique. Immunointervention is the use of pharmacological agents to modify the action of the immune system for the benefit of the patient. The practice is as old as vaccination but, with the recent increase in basic immunological knowledge and the availability of therapeutic quantities of immunological mediators made possible by genetic engineering, the number of clinical trials of such agents will increase dramatically in the 1990s. However, an understanding of immunology is still not widespread among clinical practitioners or those working in the pharmaceutical industry. This book provides guidance on how to test immunological therapies in clinical trials and how to appraise critically the results of such studies. Lessons are drawn from an evaluation of 190 clinical trials of immunotherapeutic agents, in the principle therapeutic areas of cancer, infection, autoimmune disease, and allergy. This guidance is set against an overview of basic immunological mechanisms, the ways in which they are involved in disease, and the practical problems associated with monitoring relevant features of the immune system in a clinical setting. |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical Term | Clinical immunology |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical Term | Immunologic--Therapeutic Use |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical Term | Clinical trials |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Thompson, Ronald A. |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Koha item type | Books |
| Collection code | Permanent Location | Current Location | Shelving location | Date acquired | Source of acquisition | Full call number | Accession Number | Koha item type |
|---|---|---|---|---|---|---|---|---|
| UVAS Library | UVAS Library | Pharmacology | 2015-05-20 | Purchase | 615.37 Wallace 13623 1st 1991 Pharmacology | 13623 | Books |